Silber S, Vogler A C, Spiegelsberger F, Vogel M, Theisen K
Medizinische Klinik Innenstadt, Universität München, F.R.G.
Eur Heart J. 1988 Jan;9 Suppl A:125-34. doi: 10.1093/eurheartj/9.suppl_a.125.
Little information has been published regarding the nitrate-induced changes of left ventricular volumes at rest and during exercise in relation to the degree of the anti-ischaemic response. Therefore we assessed the electrocardiographically defined nitrate response to a single tablet of 80 mg isosorbide dinitrate s.r. and compared it to the changes in end-diastolic volumes at rest and during exercise, as determined by radionuclide ventriculography. Thirty-four of the 63 patients were classified as good nitrate responders, whereas 29 patients showed insufficient nitrate response with regard to the reduction of exercise-induced ST-segment depression. The baseline characteristics were quite comparable. At rest the ISDN-induced decrease of the end-diastolic count rate was significantly less (-17%) in patients with insufficient ST-segment response when compared to patients with good ST-segment response (-25%). During exercise, in patients with good ST-segment response, ISDN reduced the end-diastolic volume significantly (-19%), whereas in patients with insufficient ST-segment response the end-diastolic volume remained unchanged. In this special subset of patients with insufficient nitrate response we further evaluated the effects of additional beta or/and calcium blockade. The benefits from verapamil were equivalent to propranolol. However, a considerable part of the patients investigated needed the combination of verapamil and propranolol for an optimal anti-ischaemic drug treatment. Thus, our data support the concept that preload reduction plays a major role for the anti-ischaemic effects of ISDN in patients with exercise-dependent ischaemia. Since, a suboptimal therapeutic effect must be considered, objective control of the nitrate therapy (usually by exercise- and Holter-ECG) must be regarded as obligatory for each individual patient if optimal results are to be expected.
关于硝酸酯类药物在静息和运动状态下引起的左心室容积变化与抗缺血反应程度之间的关系,目前发表的信息较少。因此,我们通过心电图评估了单次口服80mg缓释硝酸异山梨酯后的硝酸酯反应,并将其与静息和运动时的舒张末期容积变化进行比较,舒张末期容积变化通过放射性核素心室造影测定。63例患者中,34例被归类为硝酸酯反应良好者,而29例患者在减轻运动诱发的ST段压低方面显示出硝酸酯反应不足。两组患者的基线特征相当。静息时,ST段反应不足的患者,ISDN引起的舒张末期计数率下降明显低于(-17%)ST段反应良好的患者(-25%)。运动期间,ST段反应良好的患者,ISDN显著降低了舒张末期容积(-19%),而ST段反应不足的患者舒张末期容积保持不变。在这个硝酸酯反应不足的特殊患者亚组中,我们进一步评估了额外使用β受体阻滞剂或/和钙通道阻滞剂的效果。维拉帕米的疗效与普萘洛尔相当。然而,相当一部分接受研究的患者需要联合使用维拉帕米和普萘洛尔才能实现最佳的抗缺血药物治疗。因此,我们的数据支持这样的概念,即对于运动依赖性缺血患者,降低前负荷在ISDN的抗缺血作用中起主要作用。由于必须考虑到治疗效果欠佳的情况,若要期望获得最佳结果,对于每位患者而言,必须通过运动心电图和动态心电图对硝酸酯治疗进行客观监测。